nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2B6—Sorafenib—thyroid cancer	0.0606	0.145	CbGbCtD
Nicardipine—CYP3A5—Sorafenib—thyroid cancer	0.0478	0.114	CbGbCtD
Nicardipine—CYP2C8—Sorafenib—thyroid cancer	0.0459	0.109	CbGbCtD
Nicardipine—CYP2C19—Sorafenib—thyroid cancer	0.0385	0.0918	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—thyroid cancer	0.0368	0.0877	CbGbCtD
Nicardipine—CYP2C9—Sorafenib—thyroid cancer	0.032	0.0764	CbGbCtD
Nicardipine—ABCB1—Sorafenib—thyroid cancer	0.0311	0.0741	CbGbCtD
Nicardipine—CYP3A4—Vandetanib—thyroid cancer	0.0309	0.0737	CbGbCtD
Nicardipine—CYP2D6—Sorafenib—thyroid cancer	0.0293	0.0698	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—thyroid cancer	0.0189	0.045	CbGbCtD
Nicardipine—CYP3A4—Sorafenib—thyroid cancer	0.0186	0.0444	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—thyroid cancer	0.0178	0.0424	CbGbCtD
Nicardipine—Disease progression—Sorafenib—thyroid cancer	0.0117	0.0581	CcSEcCtD
Nicardipine—CYP3A4—Doxorubicin—thyroid cancer	0.0113	0.0269	CbGbCtD
Nicardipine—Pericarditis—Vandetanib—thyroid cancer	0.00876	0.0435	CcSEcCtD
Nicardipine—Cerebral ischaemia—Vandetanib—thyroid cancer	0.00784	0.0389	CcSEcCtD
Nicardipine—Hypophosphataemia—Sorafenib—thyroid cancer	0.0044	0.0218	CcSEcCtD
Nicardipine—Electrocardiogram ST segment depression—Epirubicin—thyroid cancer	0.00416	0.0206	CcSEcCtD
Nicardipine—Electrocardiogram ST segment depression—Doxorubicin—thyroid cancer	0.00385	0.0191	CcSEcCtD
Nicardipine—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.00351	0.0174	CcSEcCtD
Nicardipine—PDE1B—thyroid gland—thyroid cancer	0.00327	0.043	CbGeAlD
Nicardipine—PDE1B—head—thyroid cancer	0.0029	0.0382	CbGeAlD
Nicardipine—Atrial fibrillation—Vandetanib—thyroid cancer	0.0029	0.0144	CcSEcCtD
Nicardipine—PDE1A—thyroid gland—thyroid cancer	0.00274	0.0361	CbGeAlD
Nicardipine—Hypokalaemia—Vandetanib—thyroid cancer	0.0025	0.0124	CcSEcCtD
Nicardipine—PDE1A—head—thyroid cancer	0.00243	0.032	CbGeAlD
Nicardipine—CALM2—neck—thyroid cancer	0.00226	0.0296	CbGeAlD
Nicardipine—CALM1—neck—thyroid cancer	0.00225	0.0295	CbGeAlD
Nicardipine—CALM3—saliva-secreting gland—thyroid cancer	0.00224	0.0294	CbGeAlD
Nicardipine—CHRM4—head—thyroid cancer	0.00223	0.0293	CbGeAlD
Nicardipine—Pollakiuria—Vandetanib—thyroid cancer	0.0022	0.0109	CcSEcCtD
Nicardipine—Pericarditis—Epirubicin—thyroid cancer	0.00218	0.0108	CcSEcCtD
Nicardipine—Conjunctivitis—Vandetanib—thyroid cancer	0.00206	0.0102	CcSEcCtD
Nicardipine—PDE1B—lymph node—thyroid cancer	0.00203	0.0267	CbGeAlD
Nicardipine—CACNB2—thyroid gland—thyroid cancer	0.00202	0.0266	CbGeAlD
Nicardipine—Haematuria—Vandetanib—thyroid cancer	0.00202	0.01	CcSEcCtD
Nicardipine—Pericarditis—Doxorubicin—thyroid cancer	0.00202	0.01	CcSEcCtD
Nicardipine—CHRM1—saliva-secreting gland—thyroid cancer	0.00201	0.0264	CbGeAlD
Nicardipine—Sinusitis—Vandetanib—thyroid cancer	0.00199	0.00987	CcSEcCtD
Nicardipine—Peripheral vascular disorder—Epirubicin—thyroid cancer	0.00193	0.00956	CcSEcCtD
Nicardipine—CACNA2D1—thyroid gland—thyroid cancer	0.0019	0.025	CbGeAlD
Nicardipine—Visual impairment—Vandetanib—thyroid cancer	0.00183	0.0091	CcSEcCtD
Nicardipine—CHRM3—saliva-secreting gland—thyroid cancer	0.0018	0.0236	CbGeAlD
Nicardipine—CACNB2—head—thyroid cancer	0.00179	0.0236	CbGeAlD
Nicardipine—Peripheral vascular disorder—Doxorubicin—thyroid cancer	0.00178	0.00884	CcSEcCtD
Nicardipine—CACNA1D—thyroid gland—thyroid cancer	0.00177	0.0232	CbGeAlD
Nicardipine—CALM2—saliva-secreting gland—thyroid cancer	0.00176	0.0231	CbGeAlD
Nicardipine—CALM1—saliva-secreting gland—thyroid cancer	0.00175	0.023	CbGeAlD
Nicardipine—CHRM5—head—thyroid cancer	0.00174	0.0229	CbGeAlD
Nicardipine—CALM3—trachea—thyroid cancer	0.00173	0.0227	CbGeAlD
Nicardipine—PDE1A—lymph node—thyroid cancer	0.0017	0.0224	CbGeAlD
Nicardipine—Hypokalaemia—Sorafenib—thyroid cancer	0.00169	0.00838	CcSEcCtD
Nicardipine—CACNA2D1—head—thyroid cancer	0.00169	0.0222	CbGeAlD
Nicardipine—Hypophosphataemia—Epirubicin—thyroid cancer	0.00162	0.00806	CcSEcCtD
Nicardipine—ADRA1B—head—thyroid cancer	0.00159	0.0209	CbGeAlD
Nicardipine—CACNA1D—head—thyroid cancer	0.00157	0.0206	CbGeAlD
Nicardipine—Vision blurred—Vandetanib—thyroid cancer	0.00156	0.00775	CcSEcCtD
Nicardipine—ADRA1D—head—thyroid cancer	0.00156	0.0204	CbGeAlD
Nicardipine—Tremor—Vandetanib—thyroid cancer	0.00155	0.0077	CcSEcCtD
Nicardipine—CHRM1—trachea—thyroid cancer	0.00155	0.0204	CbGeAlD
Nicardipine—Hypophosphataemia—Doxorubicin—thyroid cancer	0.0015	0.00746	CcSEcCtD
Nicardipine—Erectile dysfunction—Sorafenib—thyroid cancer	0.00148	0.00733	CcSEcCtD
Nicardipine—Loss of consciousness—Vandetanib—thyroid cancer	0.00146	0.00722	CcSEcCtD
Nicardipine—CACNA1C—head—thyroid cancer	0.00145	0.019	CbGeAlD
Nicardipine—Hypertension—Vandetanib—thyroid cancer	0.00143	0.0071	CcSEcCtD
Nicardipine—Chest pain—Vandetanib—thyroid cancer	0.00141	0.007	CcSEcCtD
Nicardipine—Arthralgia—Vandetanib—thyroid cancer	0.00141	0.007	CcSEcCtD
Nicardipine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00141	0.00699	CcSEcCtD
Nicardipine—Anxiety—Vandetanib—thyroid cancer	0.0014	0.00697	CcSEcCtD
Nicardipine—Myocardial infarction—Sorafenib—thyroid cancer	0.0014	0.00695	CcSEcCtD
Nicardipine—Dry mouth—Vandetanib—thyroid cancer	0.00138	0.00684	CcSEcCtD
Nicardipine—CALM3—thyroid gland—thyroid cancer	0.00137	0.018	CbGeAlD
Nicardipine—CALM2—trachea—thyroid cancer	0.00136	0.0178	CbGeAlD
Nicardipine—Oedema—Vandetanib—thyroid cancer	0.00135	0.00671	CcSEcCtD
Nicardipine—CALM1—trachea—thyroid cancer	0.00135	0.0178	CbGeAlD
Nicardipine—Infection—Vandetanib—thyroid cancer	0.00134	0.00666	CcSEcCtD
Nicardipine—Thrombocytopenia—Vandetanib—thyroid cancer	0.00132	0.00657	CcSEcCtD
Nicardipine—CACNB2—lymph node—thyroid cancer	0.00126	0.0165	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00123	0.00611	CcSEcCtD
Nicardipine—Insomnia—Vandetanib—thyroid cancer	0.00122	0.00607	CcSEcCtD
Nicardipine—Paraesthesia—Vandetanib—thyroid cancer	0.00121	0.00602	CcSEcCtD
Nicardipine—Dyspnoea—Vandetanib—thyroid cancer	0.0012	0.00598	CcSEcCtD
Nicardipine—Tinnitus—Sorafenib—thyroid cancer	0.0012	0.00594	CcSEcCtD
Nicardipine—CHRM2—head—thyroid cancer	0.00119	0.0157	CbGeAlD
Nicardipine—Flushing—Sorafenib—thyroid cancer	0.00119	0.00591	CcSEcCtD
Nicardipine—Dyspepsia—Vandetanib—thyroid cancer	0.00119	0.0059	CcSEcCtD
Nicardipine—CACNA2D1—lymph node—thyroid cancer	0.00118	0.0155	CbGeAlD
Nicardipine—Injection site pain—Epirubicin—thyroid cancer	0.00116	0.00574	CcSEcCtD
Nicardipine—Constipation—Vandetanib—thyroid cancer	0.00116	0.00574	CcSEcCtD
Nicardipine—Pain—Vandetanib—thyroid cancer	0.00116	0.00574	CcSEcCtD
Nicardipine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00111	0.00548	CcSEcCtD
Nicardipine—CACNA1D—lymph node—thyroid cancer	0.0011	0.0144	CbGeAlD
Nicardipine—CHRM3—thyroid gland—thyroid cancer	0.0011	0.0144	CbGeAlD
Nicardipine—CHRM1—head—thyroid cancer	0.00109	0.0143	CbGeAlD
Nicardipine—Vasodilation procedure—Epirubicin—thyroid cancer	0.00107	0.00533	CcSEcCtD
Nicardipine—Vasodilation—Epirubicin—thyroid cancer	0.00107	0.00533	CcSEcCtD
Nicardipine—CALM2—thyroid gland—thyroid cancer	0.00107	0.0141	CbGeAlD
Nicardipine—Injection site pain—Doxorubicin—thyroid cancer	0.00107	0.00531	CcSEcCtD
Nicardipine—CALM1—thyroid gland—thyroid cancer	0.00107	0.014	CbGeAlD
Nicardipine—Abdominal pain—Vandetanib—thyroid cancer	0.00107	0.0053	CcSEcCtD
Nicardipine—Body temperature increased—Vandetanib—thyroid cancer	0.00107	0.0053	CcSEcCtD
Nicardipine—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00105	0.00519	CcSEcCtD
Nicardipine—Nocturia—Epirubicin—thyroid cancer	0.00102	0.00505	CcSEcCtD
Nicardipine—CACNA1C—lymph node—thyroid cancer	0.00101	0.0133	CbGeAlD
Nicardipine—Syncope—Sorafenib—thyroid cancer	0.001	0.00497	CcSEcCtD
Nicardipine—Vasodilation procedure—Doxorubicin—thyroid cancer	0.000994	0.00494	CcSEcCtD
Nicardipine—Vasodilation—Doxorubicin—thyroid cancer	0.000994	0.00494	CcSEcCtD
Nicardipine—Loss of consciousness—Sorafenib—thyroid cancer	0.000982	0.00487	CcSEcCtD
Nicardipine—Atrioventricular block—Epirubicin—thyroid cancer	0.000973	0.00483	CcSEcCtD
Nicardipine—CHRM3—head—thyroid cancer	0.000973	0.0128	CbGeAlD
Nicardipine—Asthenia—Vandetanib—thyroid cancer	0.00097	0.00481	CcSEcCtD
Nicardipine—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.000967	0.0048	CcSEcCtD
Nicardipine—Hypertension—Sorafenib—thyroid cancer	0.000964	0.00479	CcSEcCtD
Nicardipine—Neck pain—Epirubicin—thyroid cancer	0.000956	0.00474	CcSEcCtD
Nicardipine—CALM2—head—thyroid cancer	0.000952	0.0125	CbGeAlD
Nicardipine—Myalgia—Sorafenib—thyroid cancer	0.000951	0.00472	CcSEcCtD
Nicardipine—Arthralgia—Sorafenib—thyroid cancer	0.000951	0.00472	CcSEcCtD
Nicardipine—CALM1—head—thyroid cancer	0.000948	0.0125	CbGeAlD
Nicardipine—Ventricular tachycardia—Epirubicin—thyroid cancer	0.000944	0.00469	CcSEcCtD
Nicardipine—Nocturia—Doxorubicin—thyroid cancer	0.000942	0.00467	CcSEcCtD
Nicardipine—Injection site reaction—Epirubicin—thyroid cancer	0.000939	0.00466	CcSEcCtD
Nicardipine—Abnormal dreams—Epirubicin—thyroid cancer	0.000933	0.00463	CcSEcCtD
Nicardipine—Dry mouth—Sorafenib—thyroid cancer	0.00093	0.00462	CcSEcCtD
Nicardipine—Diarrhoea—Vandetanib—thyroid cancer	0.000925	0.00459	CcSEcCtD
Nicardipine—Infection—Sorafenib—thyroid cancer	0.000906	0.00449	CcSEcCtD
Nicardipine—Atrioventricular block—Doxorubicin—thyroid cancer	0.000901	0.00447	CcSEcCtD
Nicardipine—Shock—Sorafenib—thyroid cancer	0.000897	0.00445	CcSEcCtD
Nicardipine—Dizziness—Vandetanib—thyroid cancer	0.000894	0.00444	CcSEcCtD
Nicardipine—ADRA1A—head—thyroid cancer	0.000893	0.0117	CbGeAlD
Nicardipine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000893	0.00443	CcSEcCtD
Nicardipine—Neck pain—Doxorubicin—thyroid cancer	0.000884	0.00439	CcSEcCtD
Nicardipine—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.000874	0.00434	CcSEcCtD
Nicardipine—Injection site reaction—Doxorubicin—thyroid cancer	0.000869	0.00431	CcSEcCtD
Nicardipine—Abnormal dreams—Doxorubicin—thyroid cancer	0.000863	0.00429	CcSEcCtD
Nicardipine—Vomiting—Vandetanib—thyroid cancer	0.000859	0.00426	CcSEcCtD
Nicardipine—Rash—Vandetanib—thyroid cancer	0.000852	0.00423	CcSEcCtD
Nicardipine—Dermatitis—Vandetanib—thyroid cancer	0.000851	0.00423	CcSEcCtD
Nicardipine—CALM3—lymph node—thyroid cancer	0.000849	0.0112	CbGeAlD
Nicardipine—Headache—Vandetanib—thyroid cancer	0.000847	0.0042	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000831	0.00412	CcSEcCtD
Nicardipine—Hypertonia—Epirubicin—thyroid cancer	0.000828	0.00411	CcSEcCtD
Nicardipine—Abnormal vision—Epirubicin—thyroid cancer	0.000824	0.00409	CcSEcCtD
Nicardipine—Dyspnoea—Sorafenib—thyroid cancer	0.000813	0.00403	CcSEcCtD
Nicardipine—Nausea—Vandetanib—thyroid cancer	0.000803	0.00398	CcSEcCtD
Nicardipine—Dyspepsia—Sorafenib—thyroid cancer	0.000802	0.00398	CcSEcCtD
Nicardipine—Pain—Sorafenib—thyroid cancer	0.00078	0.00387	CcSEcCtD
Nicardipine—Constipation—Sorafenib—thyroid cancer	0.00078	0.00387	CcSEcCtD
Nicardipine—Hypertonia—Doxorubicin—thyroid cancer	0.000766	0.0038	CcSEcCtD
Nicardipine—Abnormal vision—Doxorubicin—thyroid cancer	0.000762	0.00378	CcSEcCtD
Nicardipine—CYP2E1—thyroid gland—thyroid cancer	0.000749	0.00985	CbGeAlD
Nicardipine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000745	0.0037	CcSEcCtD
Nicardipine—Hot flush—Epirubicin—thyroid cancer	0.000733	0.00364	CcSEcCtD
Nicardipine—Menopausal symptoms—Epirubicin—thyroid cancer	0.000726	0.00361	CcSEcCtD
Nicardipine—Body temperature increased—Sorafenib—thyroid cancer	0.000721	0.00358	CcSEcCtD
Nicardipine—Abdominal pain—Sorafenib—thyroid cancer	0.000721	0.00358	CcSEcCtD
Nicardipine—CYP2B6—head—thyroid cancer	0.000708	0.00931	CbGeAlD
Nicardipine—Hot flush—Doxorubicin—thyroid cancer	0.000678	0.00337	CcSEcCtD
Nicardipine—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000672	0.00334	CcSEcCtD
Nicardipine—Hypersensitivity—Sorafenib—thyroid cancer	0.000672	0.00333	CcSEcCtD
Nicardipine—CALM2—lymph node—thyroid cancer	0.000667	0.00877	CbGeAlD
Nicardipine—CYP2E1—head—thyroid cancer	0.000665	0.00873	CbGeAlD
Nicardipine—CALM1—lymph node—thyroid cancer	0.000664	0.00873	CbGeAlD
Nicardipine—Face oedema—Epirubicin—thyroid cancer	0.000662	0.00328	CcSEcCtD
Nicardipine—Asthenia—Sorafenib—thyroid cancer	0.000654	0.00325	CcSEcCtD
Nicardipine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000626	0.00311	CcSEcCtD
Nicardipine—Hypokalaemia—Epirubicin—thyroid cancer	0.000624	0.0031	CcSEcCtD
Nicardipine—Diarrhoea—Sorafenib—thyroid cancer	0.000624	0.0031	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—thyroid cancer	0.000612	0.00304	CcSEcCtD
Nicardipine—Dizziness—Sorafenib—thyroid cancer	0.000603	0.00299	CcSEcCtD
Nicardipine—Vomiting—Sorafenib—thyroid cancer	0.00058	0.00288	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000579	0.00288	CcSEcCtD
Nicardipine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000577	0.00286	CcSEcCtD
Nicardipine—Angina pectoris—Epirubicin—thyroid cancer	0.000577	0.00286	CcSEcCtD
Nicardipine—Rash—Sorafenib—thyroid cancer	0.000575	0.00285	CcSEcCtD
Nicardipine—Dermatitis—Sorafenib—thyroid cancer	0.000574	0.00285	CcSEcCtD
Nicardipine—Headache—Sorafenib—thyroid cancer	0.000571	0.00283	CcSEcCtD
Nicardipine—Pollakiuria—Epirubicin—thyroid cancer	0.000547	0.00272	CcSEcCtD
Nicardipine—Nausea—Sorafenib—thyroid cancer	0.000541	0.00269	CcSEcCtD
Nicardipine—ABCB1—trachea—thyroid cancer	0.000539	0.00709	CbGeAlD
Nicardipine—Angina pectoris—Doxorubicin—thyroid cancer	0.000534	0.00265	CcSEcCtD
Nicardipine—CYP2D6—head—thyroid cancer	0.000526	0.00692	CbGeAlD
Nicardipine—Conjunctivitis—Epirubicin—thyroid cancer	0.000513	0.00255	CcSEcCtD
Nicardipine—Sweating—Epirubicin—thyroid cancer	0.000506	0.00251	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—thyroid cancer	0.000506	0.00251	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—thyroid cancer	0.000504	0.0025	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—thyroid cancer	0.000496	0.00246	CcSEcCtD
Nicardipine—Rhinitis—Epirubicin—thyroid cancer	0.000475	0.00236	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000475	0.00236	CcSEcCtD
Nicardipine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000472	0.00234	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—thyroid cancer	0.000469	0.00233	CcSEcCtD
Nicardipine—Oedema peripheral—Epirubicin—thyroid cancer	0.000467	0.00232	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—thyroid cancer	0.000466	0.00231	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—thyroid cancer	0.000459	0.00228	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—thyroid cancer	0.000457	0.00227	CcSEcCtD
Nicardipine—Tinnitus—Epirubicin—thyroid cancer	0.000442	0.00219	CcSEcCtD
Nicardipine—Flushing—Epirubicin—thyroid cancer	0.00044	0.00218	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—thyroid cancer	0.00044	0.00218	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000437	0.00217	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000432	0.00215	CcSEcCtD
Nicardipine—ABCB1—thyroid gland—thyroid cancer	0.000427	0.00561	CbGeAlD
Nicardipine—Visual impairment—Doxorubicin—thyroid cancer	0.000423	0.0021	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—thyroid cancer	0.000409	0.00203	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—thyroid cancer	0.000407	0.00202	CcSEcCtD
Nicardipine—Tension—Epirubicin—thyroid cancer	0.000405	0.00201	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—thyroid cancer	0.000401	0.00199	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—thyroid cancer	0.000389	0.00193	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000383	0.0019	CcSEcCtD
Nicardipine—Agitation—Epirubicin—thyroid cancer	0.000379	0.00188	CcSEcCtD
Nicardipine—ABCB1—head—thyroid cancer	0.000378	0.00497	CbGeAlD
Nicardipine—Tension—Doxorubicin—thyroid cancer	0.000375	0.00186	CcSEcCtD
Nicardipine—Malaise—Epirubicin—thyroid cancer	0.000372	0.00185	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—thyroid cancer	0.000371	0.00184	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—thyroid cancer	0.000371	0.00184	CcSEcCtD
Nicardipine—Syncope—Epirubicin—thyroid cancer	0.00037	0.00184	CcSEcCtD
Nicardipine—Palpitations—Epirubicin—thyroid cancer	0.000365	0.00181	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—thyroid cancer	0.000363	0.0018	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—thyroid cancer	0.00036	0.00179	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—thyroid cancer	0.000356	0.00177	CcSEcCtD
Nicardipine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000354	0.00176	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—thyroid cancer	0.000351	0.00174	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—thyroid cancer	0.000351	0.00174	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—thyroid cancer	0.000351	0.00174	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—thyroid cancer	0.000351	0.00174	CcSEcCtD
Nicardipine—Anxiety—Epirubicin—thyroid cancer	0.00035	0.00174	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—thyroid cancer	0.000347	0.00172	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—thyroid cancer	0.000344	0.00171	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—thyroid cancer	0.000344	0.00171	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—thyroid cancer	0.000343	0.0017	CcSEcCtD
Nicardipine—Syncope—Doxorubicin—thyroid cancer	0.000343	0.0017	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—thyroid cancer	0.00034	0.00169	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—thyroid cancer	0.000338	0.00168	CcSEcCtD
Nicardipine—Oedema—Epirubicin—thyroid cancer	0.000337	0.00167	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000336	0.00167	CcSEcCtD
Nicardipine—Infection—Epirubicin—thyroid cancer	0.000335	0.00166	CcSEcCtD
Nicardipine—Shock—Epirubicin—thyroid cancer	0.000331	0.00165	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—thyroid cancer	0.00033	0.00164	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—thyroid cancer	0.00033	0.00164	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—thyroid cancer	0.000329	0.00163	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000326	0.00162	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—thyroid cancer	0.000325	0.00161	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—thyroid cancer	0.000325	0.00161	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—thyroid cancer	0.000325	0.00161	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—thyroid cancer	0.000324	0.00161	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—thyroid cancer	0.000321	0.00159	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—thyroid cancer	0.000318	0.00158	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—thyroid cancer	0.000315	0.00156	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—thyroid cancer	0.000314	0.00156	CcSEcCtD
Nicardipine—Oedema—Doxorubicin—thyroid cancer	0.000312	0.00155	CcSEcCtD
Nicardipine—Infection—Doxorubicin—thyroid cancer	0.00031	0.00154	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000307	0.00152	CcSEcCtD
Nicardipine—Shock—Doxorubicin—thyroid cancer	0.000307	0.00152	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000305	0.00151	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—thyroid cancer	0.000305	0.00151	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—thyroid cancer	0.000304	0.00151	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—thyroid cancer	0.000303	0.0015	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000301	0.0015	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—thyroid cancer	0.0003	0.00149	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—thyroid cancer	0.000299	0.00149	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—thyroid cancer	0.000297	0.00147	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—thyroid cancer	0.000291	0.00145	CcSEcCtD
Nicardipine—Pain—Epirubicin—thyroid cancer	0.000288	0.00143	CcSEcCtD
Nicardipine—Constipation—Epirubicin—thyroid cancer	0.000288	0.00143	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000284	0.00141	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—thyroid cancer	0.000282	0.0014	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—thyroid cancer	0.00028	0.00139	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—thyroid cancer	0.000278	0.00138	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—thyroid cancer	0.000278	0.00138	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—thyroid cancer	0.000277	0.00138	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000275	0.00137	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—thyroid cancer	0.000274	0.00136	CcSEcCtD
Nicardipine—Pain—Doxorubicin—thyroid cancer	0.000267	0.00132	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—thyroid cancer	0.000267	0.00132	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—thyroid cancer	0.000266	0.00132	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—thyroid cancer	0.000266	0.00132	CcSEcCtD
Nicardipine—ABCB1—lymph node—thyroid cancer	0.000265	0.00348	CbGeAlD
Nicardipine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000257	0.00127	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000255	0.00127	CcSEcCtD
Nicardipine—Hypersensitivity—Epirubicin—thyroid cancer	0.000248	0.00123	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—thyroid cancer	0.000246	0.00122	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—thyroid cancer	0.000246	0.00122	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—thyroid cancer	0.000242	0.0012	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—thyroid cancer	0.000231	0.00114	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—thyroid cancer	0.00023	0.00114	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—thyroid cancer	0.000224	0.00111	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—thyroid cancer	0.000223	0.00111	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—thyroid cancer	0.000214	0.00106	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—thyroid cancer	0.000213	0.00106	CcSEcCtD
Nicardipine—Rash—Epirubicin—thyroid cancer	0.000212	0.00105	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—thyroid cancer	0.000212	0.00105	CcSEcCtD
Nicardipine—Headache—Epirubicin—thyroid cancer	0.000211	0.00105	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—thyroid cancer	0.000206	0.00102	CcSEcCtD
Nicardipine—Nausea—Epirubicin—thyroid cancer	0.0002	0.000993	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—thyroid cancer	0.000198	0.000984	CcSEcCtD
Nicardipine—Rash—Doxorubicin—thyroid cancer	0.000197	0.000976	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—thyroid cancer	0.000196	0.000975	CcSEcCtD
Nicardipine—Headache—Doxorubicin—thyroid cancer	0.000195	0.000969	CcSEcCtD
Nicardipine—Nausea—Doxorubicin—thyroid cancer	0.000185	0.000919	CcSEcCtD
Nicardipine—CHRM4—GPCR downstream signaling—AKT1—thyroid cancer	1.44e-05	4.74e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.43e-05	4.72e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—KRAS—thyroid cancer	1.43e-05	4.71e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—KRAS—thyroid cancer	1.43e-05	4.71e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—BRAF—thyroid cancer	1.42e-05	4.68e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—TP53—thyroid cancer	1.42e-05	4.68e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—HRAS—thyroid cancer	1.42e-05	4.67e-05	CbGpPWpGaD
Nicardipine—CACNB2—Metabolism—AKT1—thyroid cancer	1.42e-05	4.67e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—HRAS—thyroid cancer	1.4e-05	4.63e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—HRAS—thyroid cancer	1.4e-05	4.63e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CCND1—thyroid cancer	1.39e-05	4.57e-05	CbGpPWpGaD
Nicardipine—CHRM5—GPCR downstream signaling—AKT1—thyroid cancer	1.38e-05	4.54e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—NRAS—thyroid cancer	1.36e-05	4.5e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—NRAS—thyroid cancer	1.36e-05	4.48e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—HRAS—thyroid cancer	1.36e-05	4.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TERT—thyroid cancer	1.35e-05	4.45e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PPARG—thyroid cancer	1.35e-05	4.45e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—NRAS—thyroid cancer	1.35e-05	4.44e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—NRAS—thyroid cancer	1.34e-05	4.43e-05	CbGpPWpGaD
Nicardipine—CACNA1D—Metabolism—AKT1—thyroid cancer	1.34e-05	4.42e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—PTEN—thyroid cancer	1.34e-05	4.42e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—HRAS—thyroid cancer	1.33e-05	4.39e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CCND1—thyroid cancer	1.33e-05	4.38e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PPARG—thyroid cancer	1.32e-05	4.36e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PPARG—thyroid cancer	1.32e-05	4.35e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PPARG—thyroid cancer	1.31e-05	4.33e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TERT—thyroid cancer	1.31e-05	4.31e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TERT—thyroid cancer	1.31e-05	4.31e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—AKT1—thyroid cancer	1.31e-05	4.31e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—HRAS—thyroid cancer	1.31e-05	4.31e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—KRAS—thyroid cancer	1.3e-05	4.29e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TP53—thyroid cancer	1.3e-05	4.28e-05	CbGpPWpGaD
Nicardipine—ADRA1D—GPCR downstream signaling—AKT1—thyroid cancer	1.29e-05	4.27e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HIF1A—thyroid cancer	1.29e-05	4.26e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—PTEN—thyroid cancer	1.28e-05	4.23e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—BRAF—thyroid cancer	1.28e-05	4.23e-05	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—AKT1—thyroid cancer	1.28e-05	4.22e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—BRAF—thyroid cancer	1.28e-05	4.21e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PPARG—thyroid cancer	1.27e-05	4.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PPARG—thyroid cancer	1.27e-05	4.19e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—BRAF—thyroid cancer	1.26e-05	4.17e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—HRAS—thyroid cancer	1.26e-05	4.17e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—HRAS—thyroid cancer	1.26e-05	4.17e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—BRAF—thyroid cancer	1.26e-05	4.16e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—HRAS—thyroid cancer	1.25e-05	4.14e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—AKT1—thyroid cancer	1.25e-05	4.13e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HIF1A—thyroid cancer	1.25e-05	4.12e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HIF1A—thyroid cancer	1.25e-05	4.12e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CCND1—thyroid cancer	1.25e-05	4.12e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—HRAS—thyroid cancer	1.24e-05	4.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—AKT1—thyroid cancer	1.24e-05	4.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—AKT1—thyroid cancer	1.24e-05	4.09e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PTGS2—thyroid cancer	1.23e-05	4.07e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PTGS2—thyroid cancer	1.23e-05	4.07e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—HRAS—thyroid cancer	1.21e-05	4e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—HRAS—thyroid cancer	1.21e-05	4e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PTEN—thyroid cancer	1.2e-05	3.98e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—AKT1—thyroid cancer	1.2e-05	3.95e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—NRAS—thyroid cancer	1.19e-05	3.94e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PTGS2—thyroid cancer	1.19e-05	3.94e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PTGS2—thyroid cancer	1.19e-05	3.94e-05	CbGpPWpGaD
Nicardipine—CACNA1C—Metabolism—AKT1—thyroid cancer	1.18e-05	3.89e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—AKT1—thyroid cancer	1.18e-05	3.88e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—KRAS—thyroid cancer	1.17e-05	3.87e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—KRAS—thyroid cancer	1.17e-05	3.86e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PTEN—thyroid cancer	1.16e-05	3.84e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	1.16e-05	3.82e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.16e-05	3.81e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—KRAS—thyroid cancer	1.15e-05	3.81e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—AKT1—thyroid cancer	1.15e-05	3.8e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—NRAS—thyroid cancer	1.14e-05	3.77e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PPARG—thyroid cancer	1.14e-05	3.77e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—NRAS—thyroid cancer	1.14e-05	3.75e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PTEN—thyroid cancer	1.13e-05	3.72e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PTEN—thyroid cancer	1.13e-05	3.72e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—AKT1—thyroid cancer	1.11e-05	3.68e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—AKT1—thyroid cancer	1.11e-05	3.68e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—AKT1—thyroid cancer	1.11e-05	3.65e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—HRAS—thyroid cancer	1.1e-05	3.65e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—NRAS—thyroid cancer	1.1e-05	3.63e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—NRAS—thyroid cancer	1.1e-05	3.63e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—AKT1—thyroid cancer	1.09e-05	3.61e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PTEN—thyroid cancer	1.08e-05	3.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PTEN—thyroid cancer	1.08e-05	3.55e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—NRAS—thyroid cancer	1.07e-05	3.55e-05	CbGpPWpGaD
Nicardipine—ADRA1B—GPCR downstream signaling—AKT1—thyroid cancer	1.07e-05	3.54e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—AKT1—thyroid cancer	1.07e-05	3.53e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—AKT1—thyroid cancer	1.07e-05	3.53e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—BRAF—thyroid cancer	1.07e-05	3.53e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.06e-05	3.5e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PTEN—thyroid cancer	1.04e-05	3.43e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PTEN—thyroid cancer	1.04e-05	3.43e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.04e-05	3.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—NRAS—thyroid cancer	1.04e-05	3.43e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.04e-05	3.42e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CCND1—thyroid cancer	1.04e-05	3.42e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—BRAF—thyroid cancer	1.03e-05	3.41e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—BRAF—thyroid cancer	1.03e-05	3.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTGS2—thyroid cancer	1.03e-05	3.41e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—KRAS—thyroid cancer	1.03e-05	3.39e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PPARG—thyroid cancer	1.02e-05	3.36e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—NRAS—thyroid cancer	1.01e-05	3.32e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—NRAS—thyroid cancer	1.01e-05	3.32e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PTEN—thyroid cancer	1e-05	3.3e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—thyroid cancer	9.99e-06	3.3e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—thyroid cancer	9.99e-06	3.3e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	9.97e-06	3.29e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PPARG—thyroid cancer	9.95e-06	3.28e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—HRAS—thyroid cancer	9.94e-06	3.28e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	9.84e-06	3.25e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—KRAS—thyroid cancer	9.84e-06	3.25e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—HRAS—thyroid cancer	9.81e-06	3.24e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—KRAS—thyroid cancer	9.79e-06	3.23e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—AKT1—thyroid cancer	9.76e-06	3.22e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—RXRA—thyroid cancer	9.71e-06	3.2e-05	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	9.69e-06	3.2e-05	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—AKT1—thyroid cancer	9.66e-06	3.19e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—NRAS—thyroid cancer	9.59e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	9.57e-06	3.16e-05	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—AKT1—thyroid cancer	9.54e-06	3.15e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—KRAS—thyroid cancer	9.47e-06	3.12e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—KRAS—thyroid cancer	9.47e-06	3.12e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PPARG—thyroid cancer	9.37e-06	3.09e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCND1—thyroid cancer	9.35e-06	3.08e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCND1—thyroid cancer	9.32e-06	3.07e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PPARG—thyroid cancer	9.29e-06	3.07e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—NRAS—thyroid cancer	9.28e-06	3.06e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—NRAS—thyroid cancer	9.28e-06	3.06e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTEN—thyroid cancer	9.25e-06	3.05e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KRAS—thyroid cancer	9.25e-06	3.05e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCND1—thyroid cancer	9.23e-06	3.04e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCND1—thyroid cancer	9.2e-06	3.04e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—thyroid cancer	9.13e-06	3.01e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTEN—thyroid cancer	9.06e-06	2.99e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTEN—thyroid cancer	9.04e-06	2.98e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PTEN—thyroid cancer	9.02e-06	2.98e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTEN—thyroid cancer	9.01e-06	2.97e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PTEN—thyroid cancer	8.99e-06	2.97e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—thyroid cancer	8.98e-06	2.96e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KRAS—thyroid cancer	8.94e-06	2.95e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NRAS—thyroid cancer	8.92e-06	2.94e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PTEN—thyroid cancer	8.91e-06	2.94e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PTEN—thyroid cancer	8.88e-06	2.93e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	8.8e-06	2.9e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—thyroid cancer	8.77e-06	2.9e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—thyroid cancer	8.75e-06	2.89e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HRAS—thyroid cancer	8.73e-06	2.88e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTEN—thyroid cancer	8.71e-06	2.87e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTEN—thyroid cancer	8.71e-06	2.87e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	8.69e-06	2.87e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—thyroid cancer	8.67e-06	2.86e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—thyroid cancer	8.65e-06	2.85e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—thyroid cancer	8.65e-06	2.85e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—thyroid cancer	8.36e-06	2.76e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—thyroid cancer	8.32e-06	2.75e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—thyroid cancer	8.26e-06	2.72e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—thyroid cancer	8.22e-06	2.71e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NRAS—thyroid cancer	8.05e-06	2.66e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—thyroid cancer	8.05e-06	2.66e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—thyroid cancer	8.05e-06	2.66e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NRAS—thyroid cancer	8.02e-06	2.65e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—thyroid cancer	8.02e-06	2.65e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—thyroid cancer	7.99e-06	2.64e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—thyroid cancer	7.99e-06	2.64e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NRAS—thyroid cancer	7.95e-06	2.62e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NRAS—thyroid cancer	7.92e-06	2.61e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—thyroid cancer	7.86e-06	2.59e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTEN—thyroid cancer	7.83e-06	2.58e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—thyroid cancer	7.83e-06	2.58e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—thyroid cancer	7.8e-06	2.57e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—thyroid cancer	7.71e-06	2.54e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—thyroid cancer	7.68e-06	2.53e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—thyroid cancer	7.6e-06	2.51e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—thyroid cancer	7.55e-06	2.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—thyroid cancer	7.55e-06	2.49e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PTEN—thyroid cancer	7.53e-06	2.48e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—thyroid cancer	7.38e-06	2.44e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—thyroid cancer	7.37e-06	2.43e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—thyroid cancer	7.35e-06	2.43e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—thyroid cancer	7.35e-06	2.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—thyroid cancer	7.35e-06	2.42e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—thyroid cancer	7.31e-06	2.41e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PTEN—thyroid cancer	7.28e-06	2.4e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PTEN—thyroid cancer	7.28e-06	2.4e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—thyroid cancer	7.11e-06	2.34e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—thyroid cancer	7.11e-06	2.34e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—thyroid cancer	7.02e-06	2.32e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTEN—thyroid cancer	6.99e-06	2.31e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—thyroid cancer	6.94e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—thyroid cancer	6.93e-06	2.29e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—thyroid cancer	6.91e-06	2.28e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—thyroid cancer	6.84e-06	2.26e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTEN—thyroid cancer	6.82e-06	2.25e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—thyroid cancer	6.82e-06	2.25e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—thyroid cancer	6.82e-06	2.25e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—thyroid cancer	6.79e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—thyroid cancer	6.79e-06	2.24e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NRAS—thyroid cancer	6.72e-06	2.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—thyroid cancer	6.71e-06	2.21e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—thyroid cancer	6.53e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NRAS—thyroid cancer	6.5e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NRAS—thyroid cancer	6.5e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—thyroid cancer	6.49e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—thyroid cancer	6.49e-06	2.14e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTEN—thyroid cancer	6.43e-06	2.12e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTEN—thyroid cancer	6.38e-06	2.1e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—thyroid cancer	6.2e-06	2.05e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—thyroid cancer	6.2e-06	2.04e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—thyroid cancer	6.16e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—thyroid cancer	6.14e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—thyroid cancer	6.13e-06	2.02e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—thyroid cancer	6.08e-06	2.01e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—thyroid cancer	6.06e-06	2e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—thyroid cancer	5.99e-06	1.98e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—thyroid cancer	5.99e-06	1.98e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—thyroid cancer	5.89e-06	1.94e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—thyroid cancer	5.87e-06	1.94e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—thyroid cancer	5.81e-06	1.92e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—thyroid cancer	5.8e-06	1.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—thyroid cancer	5.78e-06	1.91e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—thyroid cancer	5.76e-06	1.9e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—thyroid cancer	5.59e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—thyroid cancer	5.59e-06	1.85e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—thyroid cancer	5.33e-06	1.76e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—thyroid cancer	5.22e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—thyroid cancer	5.21e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—thyroid cancer	5.2e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—thyroid cancer	5.19e-06	1.71e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—thyroid cancer	5.18e-06	1.71e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—thyroid cancer	5.14e-06	1.7e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—thyroid cancer	5.13e-06	1.69e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—thyroid cancer	5.12e-06	1.69e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—thyroid cancer	5.02e-06	1.66e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—thyroid cancer	5.02e-06	1.66e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—thyroid cancer	4.97e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—thyroid cancer	4.97e-06	1.64e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—thyroid cancer	4.91e-06	1.62e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.82e-06	1.59e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—thyroid cancer	4.75e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—thyroid cancer	4.75e-06	1.57e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—thyroid cancer	4.51e-06	1.49e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—thyroid cancer	4.34e-06	1.43e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTEN—thyroid cancer	4.2e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—thyroid cancer	4.2e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—thyroid cancer	4.2e-06	1.39e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—thyroid cancer	4.03e-06	1.33e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—thyroid cancer	3.93e-06	1.3e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—thyroid cancer	3.71e-06	1.22e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—thyroid cancer	3.67e-06	1.21e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—thyroid cancer	2.42e-06	8e-06	CbGpPWpGaD
